Credo Health, a leader in technology for value-based care, has successfully secured $5.25 million in series seed funding. FCA Venture Partners led the round with existing investors that include Hannah Grey VC, FirstMile Ventures, and SpringTime Ventures.

Credo Health是基于价值的护理技术的领导者，已成功获得525万美元的系列种子资金。FCA Venture Partners与包括HannahGrey VC、FirstMile Ventures和SpringTime Ventures在内的现有投资者共同领导了这一轮投资。

Credo Health is the only company that combines both digital and manual medical record retrieval with AI-driven analysis and human expertise to ensure providers have the complete clinical picture of every patient.

Credo Health是唯一一家将数字和手动病历检索与人工智能驱动的分析和人类专业知识相结合的公司，以确保提供者拥有每位患者的完整临床信息。

This substantial investment reinforces Credo Health’s mission to build the definitive platform for value-based care providers. Its core platform, PreDx, provides the complete clinical picture for every patient while supporting risk adjustment, quality, and health equity.

这一巨额投资强化了Credo Health的使命，即为基于价值的护理提供者建立最终平台。其核心平台PreDx为每位患者提供完整的临床情况，同时支持风险调整、质量和健康公平。

“This investment is a testament to our commitment to fully support providers with the technology they need to succeed in value-based care,” said Credo Founder and CEO, Carm Huntress, expressing his excitement about the growth they’ve seen in PreDx since launching at the Vive Conference in March just 9 months ago.

Credo创始人兼首席执行官Carm Huntess表示：“这项投资证明了我们的承诺，即全力支持供应商获得成功所需的技术。”他对PreDx自9个月前在Vive会议上推出以来的增长感到兴奋。

“It’s clear that value-based care providers need a technology partner that not only empowers providers to deliver the highest quality patient care but also one that ensures accurate, up-to-date risk adjustment and quality information that meets the latest regulatory guidelines.”.

“很明显，基于价值的护理提供者需要一个技术合作伙伴，该合作伙伴不仅能够使提供者提供最高质量的患者护理，而且能够确保准确、最新的风险调整和符合最新监管准则的质量信息。”。

Credo Health’s forward momentum extends through strategic partnerships, including its recent collaboration with Vim, a middleware platform for healthcare that unlocks access to provider Electronic Health Record (EHR) workflow. This partnership enhances EHR workflow integration with AI-powered medical retrieval and analysis, connecting providers and patients for improved healthcare outcomes..

Credo Health的前进势头通过战略合作伙伴关系扩展，包括最近与Vim的合作，Vim是一个医疗保健中间件平台，可以打开对提供商电子健康记录（EHR）工作流程的访问。这种合作关系增强了EHR工作流程与人工智能支持的医疗检索和分析的集成，将提供者和患者联系起来，以改善医疗保健效果。。

“We’ve been looking deeply at technology across the value-based care market and it was clear to us the team and technology were far superior to anything else we evaluated. We could not be more excited about our investment in Credo and the timing as we continue to see significant growth in value-based care,” said Tom Hearn, Partner at FCA Venture Partners and now Credo board member..

FCA Venture Partners合伙人、现任Credo董事会成员汤姆·赫恩（Tom Hearn）表示：“我们一直在深入研究价值型护理市场的技术，很明显，团队和技术远远优于我们评估的其他任何项目。我们对Credo的投资和时机感到无比兴奋，因为我们继续看到价值型护理的显着增长。”。。

Currently working with leading value-based care organizations, Credo Health’s PreDx product has yielded impressive results, with organizations achieving much more accurate risk adjustment and quality scores while supporting higher quality care and patient satisfaction scores. These funds will further strengthen Credo’s technological infrastructure, expand its sales team, and continue driving innovation within the value-based care market..

目前，Credo Health的PreDx产品与领先的基于价值的护理组织合作，取得了令人印象深刻的成果，各组织实现了更准确的风险调整和质量评分，同时支持更高质量的护理和患者满意度评分。这些资金将进一步加强Credo的技术基础设施，扩大其销售团队，并继续推动基于价值的护理市场的创新。。

Credo will be attending the JP Morgan Annual Healthcare Conference and is excited to meet with top VBC providers, payers, and investors.

Credo将出席摩根大通年度医疗保健会议，并很高兴与顶级VBC提供商、付款人和投资者会面。

About Credo

关于Credo

Credo Health’s PreDx product offers a pre-encounter risk analysis, clinical summaries, and HEDIS Gap Closure through an AI-enabled analysis of digital medical records, allowing healthcare providers to make more informed clinical decisions and deliver more personalized care. Through its innovative solutions, Credo is transforming healthcare, facilitating better decision-making, and driving meaningful progress in the industry.

Credo Health的PreDx产品通过人工智能对数字医疗记录进行分析，提供遭遇前风险分析、临床总结和HEDIS差距缩小，使医疗保健提供者能够做出更明智的临床决策，并提供更个性化的护理。通过其创新的解决方案，Credo正在改变医疗保健，促进更好的决策，并推动行业取得有意义的进步。

For more information, visit credohealth.com..

有关更多信息，请访问credohealth.com。。

About FCA Venture Partners

关于FCA Venture Partners

FCA Venture Partners is a venture capital firm investing in early-stage healthcare technology and technology-enabled healthcare services companies that improve patient care, reduce costs, or increase efficiency. FCA manages over $225 million and invests across the Series Seed to Series B stages. FCA brings portfolio companies valuable healthcare insights, connections, and board-level experience to accelerate growth and build disruptive and sustainable businesses.

FCA Venture Partners是一家风险投资公司，投资于早期医疗保健技术和技术支持的医疗保健服务公司，以改善患者护理，降低成本或提高效率。FCA管理着超过2.25亿美元的资金，投资于从种子系列到B系列的各个阶段。FCA为投资组合公司带来了宝贵的医疗保健见解、联系和董事会层面的经验，以加速增长并建立颠覆性和可持续性的业务。

Based in Nashville, the epicenter of healthcare innovation, and Charlotte, the FCA team has a decades-long track record including more than 60 investments in the rapidly changing healthcare industry..

FCA团队位于医疗创新中心纳什维尔和夏洛特，拥有数十年的业绩记录，其中包括在快速变化的医疗行业进行的60多项投资。。

Originally announced January 4th, 2024

最初于2024年1月4日宣布

TagsCarm Huntress Credo Health FCA Venture Partners FirstMile Ventures Hannah Grey VC Health IT Funding Health IT Fundings Health IT Investment SpringTime Ventures Tom Hearn Vim

TagsCarm Huntess Credo Health FCA Venture Partners FirstMile Ventures Hannah Grey VC Health IT Funding Health IT Fundings Health IT Investment SpringTime Ventures汤姆·赫恩·维姆

Get Fresh Healthcare & IT Stories Delivered Daily

每天提供新鲜的医疗保健和IT故事

Join thousands of your healthcare & HealthIT peers who subscribe to our daily newsletter.

加入成千上万订阅我们每日新闻稿的healthcare&HealthIT同行。

We respect your privacy and will never sell or give out your contact information

我们尊重您的隐私，绝不出售或泄露您的联系信息